AgostiA., BiasoliS., BertacciniG.: Action of caerulein on pancreatic secretion in man. Pharmacol. Res. Comm., 2; 125–133 (1970).
2.
AgostiA., BiasoliS., BertacciniG.: Action of caerulein on gastric secretion in man. Gastroenterology, 59; 727–730 (1970).
3.
AnastasiA., ErspamerV., EndeanR.: Isolation and structure of caerulein, an active decapeptide from the skin of Hyla Caerulea. Experientia, 23; 699–700 (1967).
4.
Bahring-KuhlmeyS. R.: Ceruletido. Ceruletid, Drugs Today, 15; 13–18 (1979).
5.
BernardiL., BosisioG., De CastiglioneR., GoffredoO.: Synthesis of caerulein. Experientia, 700–701 (1967).
6.
BertacciniG., AgostiA.: Action of caerulein on intestinal motility in man. Gastroenterology, 60; 55–63 (1971).
7.
BertacciniG., BraibantiT., UvaF.: Cholecystokinetic activity of the new peptide caerulein in man. Gastroenterology, 56; 862–867 (1969).
8.
BertacciniG., De CaroG., EndeanR., ErspamerV., ImpicciatoreM.: The action of caerulein on the systemic arterial blood pressure of some experiential animals. Brit. J. Pharmacol., 33; 59–71 (1968).
9.
CorazziariE., TonelliF., PozzessereC., DaniS., AnziniF., TorsoliA.: The effects of graded doses of caerulein on human jejunal motor activity. Rend. Gastroenterol., 8; 190–193 (1973).
10.
De GregoriM., ComesP.: Ceniletide e motilità intestinale. Gazz. Med. It., 138; 345–350 (1979).
11.
Del VecchioA., BiancoC., IorioR. E., GuardascioneF.: Confronto tra effetto della ceruleina e della pentagastrina sulla secrezione gastrica nell'uomo. Rass. Inter. Clin. Ter., 59; 577–583 (1979).
12.
FrigoG. M., LecchiniS., FalaschiC., Del TaccaM., CremaA.: on the ability of caerulein to increase propulsive activity in the isolated small and large intestine. Arch. Pharmacol., 268; 44–58 (1971).
13.
FumotoT., WatanukiT.: Effect of caerulein on post-operative intestinal peristalsis. Farmaco (Prat.), 30; 579–584 (1975).
14.
HaasW., RueffF. L.: Clinical experience with ceruletide in the treatment of ileus. Scand. J. Gastroenterol., 13; suppl. 49, II Symposium, Norway 1978.
15.
HornJ., AltunbayS., HerfarthCh.: Ceruletide in the treatment of postoperative intestinal atonia. Scand. J. Gastroenterol., 13; suppl. 49, II Symposium, Norway 1978.
16.
JonesR. S., GrossmanM. I.: Choleretic effects of cholecistokinin, Gastrin II and caerulein in the dog. Amer. J. Physiol., 210; 1014–1018 (1970).
17.
LanfranchiG. A., BortolottiM., MiglioliM., BaldiP.: Azione della ceruleina sulla motilità del colon. Minerva gastroenterol., 19; 78–86 (1973).
18.
MatsushitaA., ItohS.: Pharmacological properties of a CCK- analogous peptide. Abstract. p. 38–39. World P.R.S. Kyoto, Japan, aprile 1982.
19.
NovakD.: Acceleration of small intestine contrast study by ceruletide. Proc. 11th Intern. Congr. Hamburg, p. 7, giugno 1980.
20.
PontiroliA. E., AlberettoM., VegetoG., DossiG.: The effect of ceruletide on arterial blood pressure and heart rate: a double blinde controlled study in normal volunteers. Farmaco, 36; 107–110 (1981).
21.
PughonisiA., NuzzoG., MigistrelliP., CostamagnaG.: Ceruletide pharmacodynamic test during preoperative radiomanometry in biliary surgery. Proc. 11th Intern. Congr. Hamburg, p. 6, giugno 1980.
22.
YamazakiM.: Use of caerulein for acceleration of the small intestinal roentgenographic examination. Japan. J. Clinic. Radiol., 24; 693–698 (1979).
